The effect of methylenetetrahydrofolate reductase C677T common variant on hypertensive risk is not solely explained by increased plasma homocysteine values

Abstract

The C677T transition of methylenetetrahydrofolate reductase (MTHFR) gene causes a moderate increase in total plasma homocysteine (tHcy). We studied the effect of MTHFR TT homozygosity and mild hyperhomocysteinemia on arterial hypertension. Normotensive controls (n = 223) and hypertensive subjects (n = 235) were matched for age, gender, and history of cardiovascular disease. Homocysteine levels were measured by a fluorescense polarization immunoassay method. Methylenetetrahydrofolate reductase genotypes were determined by polymerase chain reaction and restriction fragment analysis. Hypertensives showed elevated tHcy compared to normotensive group in men (P= 0.039). Homocysteine values higher than 15 mumol/L were associated with increased hypertensive risk in the male population [odds ratios (OR) = 1.63; 95% confidence interval (CI) =1.06-2.52; P = 0.027]. In multivariate analysis, TT genotype was associated with an increased risk of hypertension in males (OR = 2.27; 95% CI = 1.12-4.60; P = 0.022). An increased hypertensive risk was observed in those TT males with tHcy levels higher than 15 mumol/L (OR= 2.78; 95% CI= 1.05-7.3; P = 0.032) but not in those non-TT males with tHcy levels higher than 15 mumol/L (P=0.33). Our findings do not support the possibility that mild hyperhomocysteinemia may solely account for the hypertensive risk associated to the TT genotype.